BSE Live
Dec 05, 16:01Prev. Close
948.85
Open Price
947.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 05, 15:59Prev. Close
949.25
Open Price
945.00
Bid Price (Qty.)
933.60 (3)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Natco Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 154.41 | 141.45 | 112.33 | 82.51 | 63.98 | |
| Net CashFlow From Operating Activities | 124.55 | 171.79 | 70.02 | 68.01 | 32.29 | |
| Net Cash Used In Investing Activities | -147.95 | -130.64 | -124.24 | -128.57 | -83.41 | |
| Net Cash Used From Financing Activities | 22.80 | -40.96 | 29.17 | 61.97 | 79.50 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.59 | 0.19 | -25.04 | 1.41 | 28.38 | |
| Cash And Cash Equivalents Begin of Year | 6.86 | 6.67 | 31.71 | 30.30 | 1.91 | |
| Cash And Cash Equivalents End Of Year | 6.27 | 6.86 | 6.67 | 31.71 | 30.30 |
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
24.11.2025
24.11.2025
26.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
24.11.2025
Natco Pharma Standalone September 2025 Net Sales at Rs 1,264.30 crore, down 2.19% Y-o-Y
14.11.2025
Natco Pharma Consolidated September 2025 Net Sales at Rs 1,363.00 crore, down 0.59% Y-o-Y
09.09.2025
Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y